**FDA-approved Indication**

- Omeprazole is indicated for the short-term treatment of peptic ulcer disease in adults, where most patients heal within four weeks.

- Patients with duodenal ulcer disease and H. pylori infection that is active for up to one year may benefit from combination therapy of omeprazole with clarithromycin, amoxicillin, and metronidazole.Â Studies show a reduced recurrence of duodenal ulcers with H. pylori treatment and a reduced rate of clarithromycin resistance with quadruple therapy.

- Omeprazole is also indicated for gastric ulcers in adults.

- Omeprazole is indicated for gastroesophageal reflux disease in pediatric and adult populations.

- Omeprazole is also indicated for healing erosive esophagitis in both adults and children.

- Omeprazole is indicated for conditions prone to hypersecretion, such as Zollinger-Ellison syndrome, multiple endocrine adenomas, and systemic mastocytosis in adults.

- Uncomplicated heartburn (OTC use)

**Non-FDA-approved Indications**

- Barrett esophagus

- Stress ulcer prophylaxis